dapsone has been researched along with Community Acquired Infection in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pneumonia is an important cause of morbidity and mortality in the United States." | 2.39 | Prevention of community-acquired and nosocomial pneumonia. ( Santos, MR; Simberkoff, MS, 1996) |
| "Bacteremia was caused by Staphylococcus aureus (23%), Pseudomonas aeruginosa (18%), Escherichia coli (16%), Streptococcus pneumoniae (14%) and others (31%)." | 1.29 | Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole. ( Edge, MD; Rimland, D, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edge, MD | 1 |
| Rimland, D | 1 |
| Simberkoff, MS | 1 |
| Santos, MR | 1 |
1 review available for dapsone and Community Acquired Infection
| Article | Year |
|---|---|
Prevention of community-acquired and nosocomial pneumonia.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacterial Vaccines; Community-Acquired Infections; Cross I | 1996 |
1 other study available for dapsone and Community Acquired Infection
| Article | Year |
|---|---|
Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Bacteremia; Community-Acquired | 1996 |